Cancer Conferences, Euro Cancer 2024, cancer Europe conferences, Cancer USA, Japan, China conferences, Oncology Conferences, Cancer Therapy Meetings, World Cancer Conferences, Cancer Research Conferences, Cancer Sciences Spain Europe, Oncologists Conferences, International cancer conferences, European cancer conferences

Renowned Speakers

Rizwana Popatia

Weill Cornell Medical College, USA

Joao Paulo Martins do Carmo

State University of Goias, Brazil

Hilary Whyte

University of Toronto, Canada

Yifan Li

shanxi cancer hospital, China

Kamal D. Mehta

The Ohio State University, USA

Octavian Bucur

Viron Therapeutics USA

Emmanuelle Charafe-Jauffret

University of Mediterranee France

Debdulal Roy

Swansea University, UK

Euro Cancer 2024

About Conference

On behalf of Scientific Organizing Committee we are overwhelmed to welcome all the participants to attend 46^th Euro-Global Summit on Cancer Therapy & Radiation Oncology is scheduled for December 12-13, 2024 in Rome, Italy. Euro Cancer 2024 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. Euro Cancer 2024 is a two day event consisting of a lettered scientific program, laudable talks by the top notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available cancer therapies worldwide innovative research products which can be exhibited for further development in Oncology. This Cancer Congress is going to be the largest and most promising international conference that specifically focuses on the Radiation therapy by bringing all Renowned Radiation Oncologists under one roof. This is a two days multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

Importance & Scope

Euro Cancer 2024 will be the best platform for all the oncologists, hematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an attempt to understand the primary biological approach which is enhanced to increase potency, precision, survivability and quality of life.

The Euro Cancer 2024 is the premier event that brings together International experts, Training Institutes, Pharmacy Industries, Manufacturing, Business Entrepreneurs, Medical Devices Companies Medical Colleges, Researchers, Physicians, Academicians, Students, Academic scientists, Post Docs, Industry professionals, Diagnostic laboratory professionals across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists to reduce the to reduce the global burden of cancer.

Euro Cancer 2024 is an extraordinary event designed for International medical health professionals and oncologists to facilitate the dissemination and application of new research findings related to Cancer. The conference invites participants from all leading universities, clinical research institutions and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques.

Target Audience:

Academicians
Oncologists
Pathologists
Cancer & Oncology Societies Professionals
Bio-Medical Company professionals
Corporate Cancer Research Professional
Research Scholars
Pharmacists
Business Entrepreneurs
Software Developing Companies
Medical Devices Companies
Biotechnology Companies

Why you should attend Euro Cancer 2024?

International conferences are great opportunities not only for researchers and scientists, but also for experts, policy makers, stakeholders and students. Here are six reasons for you to attend International conferences in your field. There is an abundance of academic conferences today as compared to the past. This brings us to a simple question, “Why should one attend an academic conference?” Below are reasons why people say they attend our conferences.

At a conference, innovative ideas are thrown about and new information is exchanged among experts. Its purpose could be one of the following: An academic conference is a gathering of scientists or academicians, where research findings are presented or a workshop is conducted. Attending a seminar has numerous benefits, including improving communication skills, gaining expert knowledge, networking with others and renewing motivation and confidence.

Enlightening public with recent advances in Cancer diagnosis and therapy from around the world focused on cancer about recent advances in Cancer diagnosis and therapy, this is your single best opportunity to reach the largest assemblage of participants. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are hallmarks of this conference. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Oncology and Cancer.

Young Researchers Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole.

Sessions and Tracks

In accumulation to the multidisciplinary talks, Keynote sessions, Plenary Talks and Poster Presentations relevant to cancer & oncology research, the Euro Cancer 2024 is a complete 2-days event with board considerations.

Euro Cancer 2024 has been designed with many interesting and informative scientific sessions; it includes all possible aspects of oncology research.

The conference is CME & CPD Accredited.

Track 1: Cancer Therapy

Cancer therapy encompasses a range of treatments aimed at eradicating or controlling cancer cells. Common approaches include surgery to remove tumors, radiation therapy to target and destroy cancer cells with high-energy rays, and chemotherapy to kill cancer cells using drugs. Targeted therapies and immunotherapies work by focusing on specific molecules involved in cancer growth or by harnessing the immune system to attack cancer cells. Hormone therapy blocks or removes hormones that fuel certain cancers. Each treatment option is tailored to the individual, depending on the cancer type, stage, and overall health. Advances continue to improve effectiveness and reduce side effects.

European Cancer Societies: Children's Cancer Association, French Society of Oncology Pharmacy, French Society of Oncology Pharmacy, Belgian Association of Oncological Radiotherapy, Cancer Registry Bavaria, European Cancer Organization.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynecologic Oncology Group. American Association for Cancer Research

Asian Cancer Societies: Chinese Anti-Cancer Association, Japanese Breast Cancer Society, Japan Lung Cancer Society, Federation of Asian Organizations for Radiation Oncology, Asian Cancer Foundation.

Track 2: Cancer Targeted Therapies

Cancer Targeted Therapies focus on attacking cancer cells by targeting specific molecules involved in cancer growth and spread. Unlike traditional treatments like chemotherapy, which affects both healthy and cancerous cells, targeted therapies aim at molecular changes unique to cancer. These treatments include monoclonal antibodies that bind to cancer cell markers and tyrosine kinase inhibitors (TKIs) that block cell signaling pathways driving cancer growth. Targeted therapies are especially effective for cancers with identifiable mutations, such as breast and lung cancers. While offering fewer side effects, these therapies are not applicable to all cancers, and research is ongoing to expand their reach.

European Cancer Societies: Dutch Society for Surgical Oncology, German Society of Radiation Oncology, Childhood Cancer Research Group, Association of Population-based Cancer Registries in Germany, French Society of Radiation Oncology, Children's Cancer Association.

USA Cancer Societies: Colon Cancer Alliance, American Childhood Cancer Association, American Society for Radiation Oncology, Children's Neuroblastoma Cancer Foundation, Musculoskeletal Tumor Society, American Association for Cancer Research

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 3: Oncology Nursing

Oncology nursing focuses on caring for patients with cancer throughout their treatment journey. Oncology nurses play a crucial role in administering chemotherapy, managing symptoms, providing education, and offering emotional support. They monitor patients for side effects, coordinate care with other healthcare professionals, and advocate for patient needs. Their expertise includes understanding complex treatment regimens and addressing the physical and psychological impacts of cancer. Oncology nurses also educate patients and families about disease management, coping strategies, and self-care techniques. Their holistic approach ensures comprehensive care, enhancing the quality of life and supporting patients through their cancer experience.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group, American Association for Cancer Research

Track 4: Cancer Prevention

Cancer prevention involves strategies to reduce the risk of developing cancer. Key measures include adopting a healthy lifestyle, such as maintaining a balanced diet, engaging in regular physical activity, and avoiding tobacco and excessive alcohol consumption. Vaccinations, like those against human papillomavirus (HPV) and hepatitis B, can protect against certain cancers. Regular screenings and early detection, such as mammograms and colonoscopies, help identify cancers at an early, more treatable stage. Additionally, protecting skin from excessive sun exposure and managing environmental and occupational risks are important. These proactive measures collectively contribute to reducing cancer incidence and improving overall health.

Track 5: Cancer Research

Cancer research focuses on understanding the complexities of cancer to develop effective treatments and preventive measures. It encompasses studying cancer biology, identifying genetic and environmental risk factors, and exploring new therapies. Researchers investigate how cancers grow, spread, and respond to various treatments, including targeted therapies and immunotherapies. Clinical trials play a crucial role in evaluating new treatments and improving existing ones. Advances in cancer research aim to enhance early detection, personalize treatment, and ultimately find cures. By continually expanding knowledge and innovation, cancer research strives to reduce the burden of cancer and improve patient outcomes globally.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 6: Breast Cancer

Recent advancements in breast cancer research have opened new horizons in treatment and understanding. Innovations like targeted therapies and immunotherapies are transforming treatment outcomes by attacking cancer cells more precisely and effectively. Additionally, advancements in early detection methods, such as liquid biopsies and imaging technologies, offer improved chances for early intervention and better prognoses. These developments signify a hopeful shift towards more personalized and effective treatments, aiming to enhance survival rates and quality of life for breast cancer patients.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 7: Radiation Therapy

Use of Radiation to kill diseased cells has become a standard diagnosis option for a wide range of malignancies. It utilizes X-rays, gamma rays, electron beams or protons to treat cancer. Radiotherapy can be used in three modalities: – Adjuvant radiotherapy, Palliative radiotherapy and Curative radiotherapy. Among all the available Anti-cancer therapies, Radiation therapy is the most conventional method for treating Cancers. Success depends on early diagnosis, the volume and histological nature of the Cancer. Techniques in Radiation therapy include Gamma Knife surgery, Medical dosimetry, Three-Dimensional Conformal Radiation Therapy, Triggered imaging radiosurgery, Brachytherapy, External Beam Radiation Therapy, Intensity Modulated Radiation Therapy, mage-Guided Radiotherapy, radioisotope therapy, Total Body Irradiation, Total Skin Irradiation and Stereotactic body radiation therapy.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 8: Cancer Case reports

Most cancers are a set of more than a hundred syndromes that expand all the way through time in any of the body’s materials. Each type of cancer has its particular capabilities; the simple procedures that produce most cancers are pretty comparable in all sorts of the diseases. A case record is the identified document of signs and symptoms, prognosis, remedies of the exceptional wounded of positive scientific records with unique therapeutic strategies. As about 7.6 million of latest instances of malignancy documented every year, half of them are from developing countries. Case reports will be up to date from all the statistics from the beyond.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 9: Oncology

Oncology embraces full range of Nonsurgical Cancers including the Chemotherapy, Radiotherapy, Palliative care and Biological targeted therapy. Clinical oncologists give Solid tumours with Chemotherapy, Conventional Radiotherapy, Brachytherapy, Biological therapy, Molecular targeted therapy and sometimes with multimodality trades that include the blend of two or more Anti-cancer therapies. Clinical oncologists regulate treatment by considering a range of aspects including tumour type, the site of the tumour, the stage of the disease and the patient’s general health. They then assess the relative merits of different diagnosis before presenting these to the patient so that an informed decision can be made. The branch also comprises the study of Cancer staging, Cancer epidemiology, Brachytherapy, Cancer biostatistics etc.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 10: Cancer Immunotherapy

Cancer immunotherapy is a treatment that harnesses the body's immune system to fight cancer. It works by stimulating the immune system to recognize and destroy cancer cells or by enhancing its natural ability to do so. Types of immunotherapy include checkpoint inhibitors, which block proteins that prevent immune cells from attacking cancer, CAR T-cell therapy, which modifies a patient’s T-cells to target cancer, and cancer vaccines, which boost immune responses against tumors. Immunotherapy has shown success in treating cancers like melanoma, lung, and kidney cancer. However, not all cancers respond to this approach, and side effects can vary.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 11: Cancer Personalized Medicine

Cancer personalized medicine tailors treatment to the individual characteristics of a patient’s cancer, based on their genetic makeup and the specific mutations driving the disease. This approach contrasts with one-size-fits-all treatments like chemotherapy. By analyzing the genetic profile of a tumor, doctors can identify targeted therapies, such as drugs that inhibit cancer-specific mutations, making treatments more effective and reducing side effects. Personalized medicine includes techniques like genomic testing, which guides treatment choices, and precision therapies, such as targeted therapies or immunotherapies. This approach is especially useful in cancers like breast, lung, and colorectal, where specific mutations can be identified and treated.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 12: Cancer Vaccines

Cancer vaccines are a type of immunotherapy designed to stimulate the immune system to recognize and attack cancer cells. Unlike traditional vaccines, which prevent infections, cancer vaccines either prevent cancer (such as the HPV vaccine) or treat existing cancer by enhancing the body’s immune response. Treatment vaccines are often tailored to the patient, using cancer cell proteins or antigens to train the immune system to target and destroy cancer cells. While still in development for many cancer types, vaccines have shown promise in preventing cancers like cervical cancer and treating certain cancers like melanoma and prostate cancer.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 13: Cancer Chemotherapy

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy may be given with a healing intent, or it may aim to prolong life or to diminish symptoms.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 14: Cancer Immunology & Immunotherapy

Cancer immunology is a division of immunology that studies deals between the immune system and cancer cells. It is an arena of exploration that aims to ascertain cancer immunotherapies to treat and delay progression of the infection. Immunotherapies can be characterized as active, passive or hybrid (active and passive). The immune response, comprising the recognition of cancer-specific antigens, methods the basis of targeted therapy (such as vaccines and antibody therapies) and tumour marker-based diagnostic tests.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 15: Cancer Diagnosis

Diagnostics plays an important role throughout Cancer treatment. Before treatment, to accurately locate Tumours, stage the disease, and determine an appropriate combination of cancer diagnosis. Diagnostics are used to track the size of the tumour, progression of the disease, and patient response to treatment, and modify your treatment accordingly. To confirm the diagnosis of most cancers, a liquid Biopsy needs is to be performed in which a tissue sample is removed from the tumour which occurred initially and studied under a microscope for detecting cancer cells. Endoscopy can be done by implanting a flexible plastic tube with a minute camera into body cavities or organs. Cancer Screening tests are used to detect the possibility of tumour cells which is present before symptoms occur. To identify cancer at its initial stage, different types of diagnostic tests are used to Screen at-risk individuals, Monitor treatment efficacy and disease progression or recurrence, Predict prognosis and direct treatment, Monitor an asymptomatic population for the early discovery of cancer, Earlier detection and treatment consequently drops cancer mortality, Diagnose a primary cancer and recognize the cancer subtype after whole cancer treatment, to display for any signs of metastasis or recurrence.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 16: Cancer Drugs

Cancer or its dealings can lower your resistance to infection and make you more likely to catch the other diseases. There are many diverse types of cancer drugs. Some medications can treat cancer and the others help to dismiss symptoms such as aching and sickness. The type of drugs you need to use for cure of your cancer depends on what type of cancer you have. Drug therapies work in various ways to extinguish cancer cells and discontinue them from diffusion or slow down their progress. Anticancer drugs or anticancer agents are used in Cancer. Drugs may also be used to decrease or relieve side effects of cancer and its treatment.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 17: Hematology- Oncology

Hematology- Oncology is the division of medicine associated to the study of diagnosis, treatment, and prevention of blood diseases and cancer. It includes such diseases as iron deficiency anemia, hemophilia, sickle cell disease, the thalassemia, leukemia and lymphoma. The study of hematology integrates clinical and laboratory medicine. Leukemia affects your white blood cells. These are major, infection-fighting part of your immune system, made in your bone marrow. The cancerous formation affecting the lymphocytes is called as lymphoma. Lymphocytes are one of the variabilities of white blood corpuscles. As part of Myeloma, the plasma is affected by the tumor cells. Blood cancers can cause many different symptoms. Some are mutual across all blood cancers, others are more distinctive of types of blood cancer. For example, lymphomas can be recognized by swollen lymph nodes and one of the most common symptoms of myeloma is bone pain, especially in the back.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 18: Cancer & Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or avoid a disease or illness. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is using to prevent the disease. Stems cells transplant is used to treatment of cancer like leukaemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains haematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 19: Cancer Nanotechnology

The traditional use of nanotechnology in cancer therapeutics has been to improve the pharmacokinetics and reduce the systemic toxicities of chemotherapies through the selective targeting and delivery of these anticancer drugs to tumour tissues.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 20: Cancer Pharmacology

Cancer pharmacology plays an important role in medication development. In both the laboratory and the hospital, cancer pharmacology has had to adjust to the changing face of drug expansion by forming experimental representations and target orientated methods. It also emphases on developing new approaches to the clinical dealing of cancer over research that bridges the arenas of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. It usually involves the pharmacological and oncological aspects of drugs at both.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 21: Cancer Epidemiology

Cancer Epidemiology includes the study of the factors affecting cancer, to infer possible trends and causes. The study of cancer epidemiology practices epidemiological methods to find the origin of cancer and to recognize and develop enhanced treatments. It can be used to recognize events that increase or decrease cancer frequency in specific populations. The studies related to population-based research on cancer etiology, prevention, surveillance and survivorship, analytical, and molecular epidemiology, survivorship studies, risk factors, as well as the role of behavioural factors in cancer etiology and prevention are also included.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 22: Cancer Therapy & Treatments

Cancer can be cured by different methods. The choice of therapy depends upon the location and mark of the tumour and the stage of the disease, as well as the overall state of the patient. Many experimental cancer treatments are also below development. Some people with tumors will have only one treatment. But most people have a group of treatments, such as surgery with chemotherapy and/or radiation therapy.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 23: Oncology: Sub-Specialities

Oncology is a subdivision of medicine that compacts with the prevention, diagnosis, and treatment of cancer. Unlike cancers affecting different parts of the body e.g. prostate, breast, lungs, blood cells or other organs behave in diverse manner are of different grades and cellular type, respond differently to treatment and have different set of effective treatment regimen. An oncologist is a doctor who treats cancer. Within oncology there are numerous sub-specialities that deal with different types of cancer.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 24: Precision Cancer Medicine & Oncology

Precision medicine is the modifying of medical treatment to the individual features of each patient and his or her disease. Furthermore, through the precision medicine method, the treatment of each patient can be absorbed on drugs most likely to advantage him or her, sparing the patient the cost and probable harmful side effects from drugs that are suspect to be beneficial. Oncology has been foremost precision medicine determinations largely because of our massive knowledge of the role of genetic mutations in the development and progression of cancer. Precision medication enables to approach detection, diagnosis and treatment in an in-depth way to regulate how a cancer develops, grows and spreads.

USA Cancer Societies: National Cancer Institute, American Childhood Cancer Association, National Brain Tumor Society, American Cancer Society, Gynaecologic Oncology Group.

Track 25: Complementary & Alternative Methods and Cancer

Alternative cancer treatments may not perform a direct role in curing your cancer, but they may help you manage with signs and symptoms affected by cancer and cancer treatments. CAM is the word for medical products and practices that are not part of standard care. Incorporating the best of evidence-based opposite and alternative cancer treatments with the actions you receive from your doctor may help release many of the symptoms related with cancer and its treatment.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Track 26: Cancer: Lifestyle Connection and Nutrition

Many factors influence the development of cancer. Over the last 35 years, science has shown that physical activity, diet and body weight—especially being overheavy or obese is major risk influences for developing certain types of cancer. About a third of the most mutual cancers could be prohibited through lifestyle changes. The main interactive and environmental risk factors for cancer humanity in the world are related to diet use of addictive substances, sexual and generative health and contact to air pollution and use of polluted needles. The body’s capability to resist cancer may be facilitated by following a healthy diet, staying physically active, and avoiding excess body fat. Cancer and cancer treatments can also distress your body's ability to endure certain foods and use nutrients.

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Cancer Foundation, Japan Lung Cancer Society, Cancer Relief Society Nepal.

Market Analysis

The recent advancements in the cancer treatments & cancer care are accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.

Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming growth of this market.

Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilar. Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumour cell specific genes.

The global cancer diagnostics market is segmented based on technology, application, and region. This report studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period.

Importance and Scope

Radiation therapy is one of the prominent therapies used today in the treatment of cancer. Developed countries such as U.S., Europe have already considered radiotherapy procedure as the gold standard for cancer treatment. Radiotherapy refers to therapeutic procedures using high-energy electromagnetic waves or radioactive particulates to thwart abnormal cell growths and repair different physiological abnormalities within the human body. Euro Cancer 202 2 will be the best platform for radiologists, oncologists, researchers working in this field to connect and exchange ideas.

Related Companies/Industries:

Roche
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Bristol-Myers Squibb
Galenicum
Merck & Co., Inc.
AstraZeneca
AbbVie
Eli Lilly
Pangaea Oncology
Enia Lipotech
Ability Pharma
IDP Pharma
Pensa Pharma

Related Companies/Industries:

Society of Oncology and Cancer Research of Nigeria (SOCRON)
European society for medical oncology
American Society of Clinical Oncology
Swiss Group for Clinical Cancer Research
American Institute for Cancer Research (AICR)
National Foundation for Cancer Research
Cancer Research Institute
Institute of Cancer Research, London
European Academy of Tumour Immunology (EATI)
American Association for Cancer Research (AACR)
National Cancer Institute
Cancer Research UK
Memorial Sloan Kettering Cancer Centre
Ludwig Institute for Cancer Research
National Institutes of Health (NIH)
Breast Cancer Research Foundation
Amgen
University of Texas MD Anderson Cancer Centre
World Cancer Research Fund International
AstraZeneca

Past Conference Report

Thanks to all our Speakers and conference attendees of Euro Cancer 2023 Conference

45^th Euro-Global Summit on Cancer Therapy & RadiationOncology during November 27-28, 2023 in Paris, France. The conference organized with a focus on “Exploring the Research Challenges & Advancements in Cancer and Therapeutic Strategies” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Euro Cancer 2023, we would like to announce the commencement of the “46^th Euro-Global Summit on Cancer Therapy & Radiation Oncology” to be held during December 12-13, 2024 in Rome, Italy. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology Research.

For more details: https://eurocancer.expertconferences.org/

Let us meet again @ Euro Cancer 2024